68%

IMPLANET announces Q2 2016 record revenue of €2.1 million with Spine sales growing by +68%

Bordeaux, Boston, July 12, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in…